Advertising of Therapeutic Goods in Australia – Are your advertising campaigns compliant? – Stephens Lawyers & Consultants
Posted: 23 June 2022 Advertising compliance for therapeutic goods in Australia is complex, requiring one to remain up-to-date on a number of different advertising laws which are administered by different regulators. This article provides a timely reminder that as…
First harvest at medicinal cannabis facility near Mildura in Victoria’s north-west
Posted: 16 June 2022 Key points: The first crop has been harvested from a medicinal cannabis facility built in a former fruit juice factory near Mildura Cann Group received approval to cultivate the crop at the $115 million…
Australian Technologies Competition – Call Out to Candidates
Posted: 15 June 2022 Entries Close: 4 July 2022 (11.59pm) “The Australian Technologies Competition is an internationally recognised national awards and growth support program for technology scaleups. It comprises a three stage national competition for sector awards and…
Record 65,000 flu cases in May as experts warn 2022 flu resurgence redefines what it means to be ‘flu ready’
Posted: 14 June 2022 Infectious disease experts gathered at the BioMelbourne Network BioForum today to share concerns regarding influenza (flu) preparedness, emerging public health challenges and vaccine innovation.1 According to data captured by the National Notifiable Disease…
2022 GSK Award for Research Excellence: nominations now open!
Posted: 10 June 2022 Nominations Close: 15 July 2022 The GSK Award for Research Excellence (ARE) is one of the most prestigious and longstanding awards available to the Australian medical research community. Among the previous recipients of the…
Call-For-Entries: 26th Victorian Premier’s Design Awards: Now Open
Posted: 7 June 2022 Entries Close: 29 July 2022 Entries are now open for the 26th Victorian Premier’s Design Awards, with accolades awarded across eight design categories – architecture, product design, communications, design strategy, fashion, digital, service design,…
Immutep’s TACTI-002 trial meets primary endpoint in lung cancer
Posted: 6 June 2022 Immutep reports positive Overall Response Rate in its Phase II clinical trial in 1st line NSCLC for PD-L1 all-comers TACTI-002 has met its primary objective for 1st line non-small cell lung cancer (NSCLC) patients…
Gilead Sciences awards $300,000 in funding for local research projects
Posted: 6 June 2022 Applications close: 22 August 2022 • Six successful applicants across Australia, including five women, awarded research grants as part of the Gilead Australia Fellowship: Grants Program 2022 • Awarded research projects span across the…
Committee for Melbourne – Welcome to our new CEO, Mark Melvin!
Posted: 2 June 2022. I would firstly like to say thank you to our members, stakeholders and secretariat for such a warm welcome. It is in an honour and a privilege to lead the Committee for Melbourne into…
Amplia Therapeutics (ASX:ATX) shows efficacy in model of lung fibrosis
Date posted: 2 June 2022 Amplia has released new data showing that in a head-to-head preclinical comparison, using a mouse model of idiopathic pulmonary fibrosis (IPF), AMP945 showed comparable efficacy to the current standard of care. The current…
Ed Husic is Australia’s new Industry & Science Minister
Posted: 31 May 2022 Written by – Denham Sadler National Affairs Editor InnovationAus.com Long-time tech and innovation advocate Ed Husic will be Australia’s new Industry Minister after he retained his spot in the new Labor government’s Cabinet, with Clare…
Avatar Brokers Celebrates 20 Years
Posted: 30 May 2022 Avatar Brokers are proud to announce a significant milestone in the history of our company, with this month marking our 20th anniversary. Founded on May 29, 2002, Avatar Brokers began its operations after establishing…
